Investigational CRISPR-Cas9-edited T cells for metastatic colorectal cancer treatment: Clinical insights for future development. Lou E, Foo J, Leder K. Mol Ther Oncol 2026;34:201139.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lou E, Foo J, Leder K. Investigational CRISPR-Cas9-edited T cells for metastatic colorectal cancer treatment: Clinical insights for future development. Mol Ther Oncol 2026;34:201139.
PMID: 41732760